CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes.
Eisai Oncology & Helsinn Group to Present New CINV Research at 2014 International Symposium on Supportive Care in Cancer
Eisai Oncology & Helsinn Group to Present New CINV Research at 2014 International Symposium on Supportive Care in Cancer
Wuyuan: El antiguo pueblo de China que devuelve la sensación de nostalgia de la ciudad natal de cada uno de nosotros
Simbionix presenta el primer módulo de formación VR para practicar el cierre con sutura del collarín vaginal disecado